Sort
89,613 grants matching “depression”
Alcohol Pharmacokinetics and Pharmacodynamics in Humans
$3,037,867Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2016 · AA
Women HIV Cohort Study: HIV infection and treatment among women of reproductive age
$3,035,518Maria Luisa Alcaide · University Of Miami School Of Medicine · R01 · FY2020 · HD
PHARMACOGENETICS OF MEMBRANE TRANSPORTERS
$3,034,266University Of California San Francisco · U01 · FY2001 · GM
MIND DIET AND DEMENTIA PREVENTION IN ISCHEMIC STROKE PATIENTS
$3,033,308Neelum T Aggarwal · Rush University Medical Center · R01 · FY2024 · AG
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder.
$3,032,676Fiona J. Thomson · Astrazeneca Pharmaceuticals, Lp · UG3 · FY2021 · DA
Early Markers of Alzheimer Disease
$3,029,330Susan Resnick · National Institute On Aging · ZIA · FY2019 · AG
PPD, PREVENTING POSTPARTUM DEPRESSION - A REAL-WORLD EXAMINATION OF A PREDICTIVE TEST FOR PPD
$3,028,589Dionysus Digital Health Inc · · FY2025 · Defense Health Agency
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder
$3,027,897Paul J Kenny · Eolas Therapeutics, Inc. · UH3 · FY2025 · DA
International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)
$3,025,969Matthias Egger · Universitat Bern · U01 · FY2017 · AI
A novel and highly selective orexin 1 receptor antagonist for the treatment of patients with opioid use disorder.
$3,024,162Ian Gurrell · Astrazeneca Pharmaceuticals, Lp · UH3 · FY2024 · DA
Fragmented early-life experiences, aberrant circuit maturation, emotional vulnerabilities
$3,020,227Tallie Z. Z Baram · University Of California-Irvine · P50 · FY2019 · MH
Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect
$3,019,176Carlos Zarate · National Institute Of Mental Health · ZIA · FY2020 · MH
Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
$3,019,176Carlos Zarate · National Institute Of Mental Health · ZIA · FY2020 · MH
Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project II
$3,019,032Michael Alosco · Boston University Medical Campus · R01 · FY2025 · NS
Impact of Timing, Targeting, and Brain State on rTMS of Human and Non-Human Primates
$3,016,179Marc A Sommer · Duke University · RF1 · FY2017 · MH
Cellular And Synaptic Physiology Of Hippocampal Interneurons
$3,011,240Chris J McBain · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
Mechanisms Of Synaptic Plasticity In The Adult And Developing Nervous System
$3,008,772Serena M Dudek · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Small blood pumps for small patients
$3,007,461Trevor Arnoult Snyder · Vadovations, Inc. · R44 · FY2017 · HL
IGF::OT::IGF Double-Blind, Placebo-Controlled, Proof-of-Concept (POC) Trial of Ke
$3,005,599X X · Massachusetts General Hospital · N02 · FY2013 · DA
Functional genetic analyses of existing data resources to expand AD gene discovery
$3,002,657Jennifer Below · Vanderbilt University Medical Center · RF1 · FY2019 · AG
PRIDEnet for the All of Us Research Program
$3,001,929Mitchell Ryan Lunn · Stanford University · OT2 · FY2023 · OD
International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)
$3,000,683Matthias Egger · Universitat Bern · U01 · FY2019 · AI
NIMH Center for Collaborative Genetic Studies
$3,000,000Jay Arnold Tischfield · Rutgers, The State Univ Of N.J. · U24 · FY2008 · MH
Health Outcomes around Pregnancy and Exposure to HIV/ARV (HOPE): Extending the Reach of PHACS to Examine Women's Health
$3,000,000Paige L Williams · Harvard School Of Public Health · R01 · FY2020 · HD
NICHD RADX TECH ACT ENDO CHALLENGE AWARD - INITIAL OBLIGATION
$3,000,000 · N01 · FY2024 · HD